Abstract:Abstract Background : Cancer stem cells are the important factors that lead to drug resistance, recurrence and metastasis of tumor. Immunotherapy has become the first-line treatment for advanced Hepatocellular Carcinoma(HCC), however, the importance of cancer stem cells in the immunotherapy of HCC has not been well elucidated. Methods : We identified a subset of cells with stemness characteristics by analyzing single-cell sequencing data from tumor tissue samples from 10 patients with HCC. We screened these cell populations for overexpressed genes, defined as cancer stem cell-related genes. Subsequently, we comprehensively analyzed the bulk RNA sequencing data of 365 HCC patients to construct a cancer stem cell-related genes prognostic signature(CSGPS). According to the CSGPS, 365 patients with HCC were divided into high-risk and low-risk groups. Multiple independent external cohorts were used to assess the predictive value of the CSGPS. T cell receptor (TCR) richness, Cancer Testicular Antigens (CTA) scores, Microsatellite instability (MSI), expression of immune checkpoint-related genes, and Tumour Immune Dysfunction and Exclusion (TIDE) scores were used to assess the intensity of response to immunotherapy in different risk groups. Real-time quantitative polymerase chain reaction (qRT-PCR) was used to verify the mRNA expression levels of cancer stem cell-related genes in HCC tissues. Results: CSGPS is an independent risk factor for the prognosis of HCC patients, and it is significantly superior to other clinical features in predicting the prognosis and immunotherapy response of HCC patients. Multiple independent external cohorts validated the validity and robustness of the CSGPS. Immune infiltration analysis showed that cancer stem cell-related genes can recruit immune cells with immunosuppressive functions, such as Treg, macrophages infiltration. The CSGPS was correlated with the TCR, CTA score, MSI score, expression of immune checkpoint-related genes, and TIDE score. Patients in the high-risk group identified by the CSGPS may respond more strongly to immunotherapy and be more suitable to immunotherapy. The results of qRT-PCR confirmed that 8 cancer stem cell-related genes were overexpressed in HCC tissues. Conclusion: Cancer stem cell-related genes are overexpressed in HCC and contribute to the formation of an immunosuppressive microenvironment. Targeting cancer stem cells may become a new target for immunotherapy of HCC. Our novel prognostic signatureof cancer stem cell-related genes can effectively predict the prognosis and immunotherapy response of HCC patients. In the future, the prognostic signature will help clinicians to select the appropriate population for immunotherapy and improve the response rate of immunotherapy.

Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma

Immunological Value of Prognostic Signature Based on Cancer Stem Cell Characteristics in Hepatocellular Carcinoma

Immune Classifier-Based Signatures Provide Good Prognostic Stratification and Predict the Clinical Benefits of Immune-Based Therapies for Hepatocellular Carcinoma

Cancer Stem Cells Remodel the Tumor Microenvironment and Influence Immunotherapy Response in Hepatocellular Carcinoma

Identification of cancer stem cell characteristics in liver hepatocellular carcinoma by WGCNA analysis of transcriptome stemness index

Integration of scRNA-seq and bulk RNA-seq constructs a stemness-related signature for predicting prognosis and immunotherapy responses in hepatocellular carcinoma

Identification of Immune-Related Markers in Hepatocellular Carcinoma Based on Gene Co-expression Network

Identification of a Cancer Stem Cells Signature of Head and Neck Squamous Cell Carcinoma

Integration of single-cell RNA-seq and bulk RNA-seq to construct liver hepatocellular carcinoma stem cell signatures to explore their impact on patient prognosis and treatment

Identification of a Cancer Stemness Driven Prognostic Model and Therapeutic Drug Targets by Machine Learning in Hepatocellular Carcinoma

Identification of a 9-gene signature related to stemness for prognosis in hepatocellular carcinoma basing on weighted gene coexpression network analysis

Identification of Crucial Genes Based on Expression Profiles of Hepatocellular Carcinomas by Bioinformatics Analysis.

Deep Dissection of Stemness-Related Hierarchies in Hepatocellular Carcinoma.

Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma

Identification and Validation of a Potential Stemness-Associated Biomarker in Hepatocellular Carcinoma

Identification of Hub Genes Associated With Immune Infiltration and Predict Prognosis in Hepatocellular Carcinoma via Bioinformatics Approaches

Identification of Key Genes in the HBV-Related HCC Immune Microenvironment Using Integrated Bioinformatics Analysis

Identification of Prognostic Genes in Hepatocellular Carcinoma

Identification and Validation of a New Gene Signature Predicting Prognosis of Hepatocellular Carcinoma Patients by Network Analysis of Stemness Indices.

Integrated Bioinformatics Analyses of Key Genes Involved in Hepatocellular Carcinoma Immunosuppression

Establishment and Validation of a Novel CD8+ T Cell-Associated Prognostic Signature for Predicting Clinical Outcomes and Immunotherapy Response in Hepatocellular Carcinoma Via Integrating Single-Cell RNA-seq and Bulk RNA-seq.